Bank of New York Mellon Corp cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.3% during the 4th quarter, Holdings Channel reports. The institutional investor owned 10,835,666 shares of the pharmacy operator’s stock after selling 980,953 shares during the quarter. Bank of New York Mellon Corp’s holdings in Walgreens Boots Alliance were worth $786,885,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. Commonwealth Bank of Australia boosted its position in shares of Walgreens Boots Alliance by 139.5% during the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after buying an additional 26,893 shares during the last quarter. Andra AP fonden boosted its position in shares of Walgreens Boots Alliance by 6.9% during the third quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after buying an additional 4,000 shares during the last quarter. Birinyi Associates Inc. boosted its position in shares of Walgreens Boots Alliance by 9.0% during the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after buying an additional 750 shares during the last quarter. Chesley Taft & Associates LLC boosted its position in shares of Walgreens Boots Alliance by 48.6% during the fourth quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after buying an additional 85,423 shares during the last quarter. Finally, CI Investments Inc. purchased a new position in Walgreens Boots Alliance in the third quarter worth about $27,555,000. 60.82% of the stock is currently owned by institutional investors.
Several brokerages have issued reports on WBA. Royal Bank of Canada set a $94.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Friday, February 16th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a research report on Wednesday, February 14th. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, February 13th. ValuEngine cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Mizuho set a $87.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Ten investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $85.37.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $70.91 on Wednesday. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The firm has a market capitalization of $70,250.00, a PE ratio of 19.59, a PEG ratio of 1.19 and a beta of 1.18.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the previous year, the firm earned $1.10 EPS. The business’s quarterly revenue was up 7.9% on a year-over-year basis. sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.73 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.26%. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s management believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: This article was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.com-unik.info/2018/02/21/walgreens-boots-alliance-inc-wba-position-lowered-by-bank-of-new-york-mellon-corp.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.